Appropriators To FDA: Encourage States To Sign Compounding MOU

House appropriators want FDA to make sure states sign the agency’s final memorandum of understanding for interstate distribution of pharmacy compounded drugs. Appropriators urge the agency to work with pharmacy compounding stakeholders to address concerns with the MOU, which is the subject of a lawsuit filed by seven pharmacy compounding groups. Appropriators would like to see most, if not all, 50 states sign the memorandum, the lawmakers say in their fiscal 2022 funding report released Tuesday (June 29). The directive...